ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 160 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $329 | -99.9% | 7,080 | -4.8% | 0.03% | -13.2% |
| Q3 2022 | $386,000 | -16.6% | 7,440 | +20.2% | 0.04% | -25.5% |
| Q4 2021 | $463,000 | +59.7% | 6,190 | +103.7% | 0.05% | +6.2% |
| Q1 2019 | $290,000 | -37.4% | 3,039 | -43.8% | 0.05% | -25.0% |
| Q3 2018 | $463,000 | +8.9% | 5,412 | -25.2% | 0.06% | -14.7% |
| Q4 2017 | $425,000 | +105.3% | 7,240 | +2.6% | 0.08% | +33.9% |
| Q1 2016 | $207,000 | – | 7,055 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |